This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
PLEASANTON, Calif., Dec. 18, 2013 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) will present at the 32
nd Annual J.P. Morgan Healthcare Conference in San Francisco, Calif., on January 14, 2014. Robert S. Weiss, President and Chief Executive Officer, and Albert G. White, III, Vice President and Chief Strategy Officer, will represent the Company in a presentation scheduled to begin at 2:30PM PT (5:30PM ET).
A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market-leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has over 8,000 employees with products sold in over 100 countries. For more information, please visit
CONTACT: Kim Duncan
Senior Director, Investor Relations